Cargando…
Fumarate hydratase inhibits non-small cell lung cancer metastasis via inactivation of AMPK and upregulation of DAB2
Lung cancer is one of the leading causes of cancer mortality worldwide. As it is often first diagnosed only when cancer metastasis has already occurred, the development of effective biomarkers for the risk prediction of cancer metastasis, followed by stringent monitoring and the early treatment of h...
Autores principales: | Vadhan, Anupama, Yang, Yi-Fang, Wang, Yun-Ming, Chen, Pang-Yu, Tzou, Shey-Cherng, Cheng, Kuang-Hung, Hu, Stephen Chu-Sung, Cheng, Tian-Lu, Wang, Yen-Yun, Yuan, Shyng-Shiou F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773317/ https://www.ncbi.nlm.nih.gov/pubmed/36589668 http://dx.doi.org/10.3892/ol.2022.13627 |
Ejemplares similares
-
MED12 mutations and fumarate hydratase inactivation in uterine adenomyomas
por: Heikkinen, Tuomas, et al.
Publicado: (2018) -
HIF and fumarate hydratase in renal cancer
por: Sudarshan, S, et al.
Publicado: (2007) -
Structural basis of fumarate hydratase deficiency
por: Picaud, Sarah, et al.
Publicado: (2011) -
Fumarate hydratase inactivation in hereditary leiomyomatosis and renal cell cancer is synthetic lethal with ferroptosis induction
por: Kerins, Michael J., et al.
Publicado: (2018) -
A Case of Renal Cell Carcinoma and Pheochromocytoma Due to Germline Inactivating Mutation in Fumarate Hydratase (FH)
por: Reda, Sarah Alicia, et al.
Publicado: (2021)